The same study further demonstrated that galantamine, an AChE inhibitor used clinically for AD treatment, protects neurons through activation of JNK signaling to enhance α7 nAChR expression and through inhibition of the Akt pathway to induce autophagy, thereby also promoting intracellular Aβ sequestration [52] (Table 1). Here, ACHE is linked to Alzheimer disease.